Browsing: Homepage Slider
For the first time, a treatment has been found to halt progression of Huntington’s disease by lowering levels of mutant huntingtin protein in the nervous system.
Researchers have discovered that an experimental drug appears to block the flow of toxic ions thought to cause Alzheimer’s.
Prof Kipnis describes his lab’s discovery that meningeal vessels directly link the brain with the lymphatic system, overturning decades of teaching that the brain lacks a direct connection to the immune system.
A recent re-evaluation study reported that soluble APP-α and APP-β in CSF are strongly correlated with phosphorylated tau and are potentially useful biomarkers for earlier diagnosis of dementia disorders.
A collection of the biggest news to come out of the Society for Neuroscience’s annual meeting, Neuroscience 2017, as well as interviews with the researchers behind the science.
In this #NCTalks podcast, we speak to Henrik Zetterberg; one of the world’s leading experts in fluid biomarkers for neuronal injury and degeneration.
In his latest column, David Howett reviews a recent paper from Gunn-Moore et al. on the relationship between Alzheimer’s disease and Type 2 diabetes.